Coelho Rogerio Vivaldi
CIK: 0001610381
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (13 total)
- Sep 1, 2026CRNX
Crinetics Pharmaceuticals, Inc.
Disposition(D)Direct5.9K shares at avg. $85.00$504K - Sep 1, 2026CRNX
Crinetics Pharmaceuticals, Inc.
Disposition(D)Direct13.3K shares at avg. $85.00$1.1M - Jul 2, 2026CRNX
Crinetics Pharmaceuticals, Inc.
Sale(S)Direct3K shares at avg. $40.00$120K - Jun 18, 2026CRNX
Crinetics Pharmaceuticals, Inc.
Award(A)Direct5.9K shares- - Mar 12, 2026CRNX
Crinetics Pharmaceuticals, Inc.
Sale(S)Direct4.5K shares at avg. $36.08$162K - Mar 12, 2026CRNX
Crinetics Pharmaceuticals, Inc.
Sale(S)Direct523 shares at avg. $36.77$19K - Mar 6, 2026VTRS
Viatris Inc
Exercise(M)Direct23.7K shares- - Mar 6, 2026VTRS
Viatris Inc
Award(A)DirectRestricted Stock Units
15.9K shares- - Mar 6, 2026VTRS
Viatris Inc
Exercise(M)Direct1.2K shares- - Jun 11, 2025CRNX
Crinetics Pharmaceuticals, Inc.
Award(A)Direct6.9K shares- - Mar 6, 2025VTRS
Viatris Inc
Award(A)DirectRestricted Stock Units
23.7K shares- - Mar 4, 2025VTRS
Viatris Inc
Exercise(M)Direct424 shares- - Mar 4, 2025VTRS
Viatris Inc
Exercise(M)Direct21.3K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 1, 2026 |  CRNX Crinetics Pharmaceuticals, Inc. | Disposition(D) | 5,925 | $85.00 | $503,625 | Direct |
| Sep 1, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | Disposition(D) | 13,300 | $85.00 | $1,130,500 | Direct |
| Jul 2, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | Sale(S) | 3,000 | $40.00 | $120,000 | Direct |
| Jun 18, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | Award(A) | 5,925 | - | $0 | Direct |
| Mar 12, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | Sale(S) | 4,477 | $36.08 | $161,530 | Direct |
| Mar 12, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | Sale(S) | 523 | $36.77 | $19,231 | Direct |
| Mar 6, 2026 |  VTRS Viatris Inc | Exercise(M) | 23,660 | - | $0 | Direct |
| Mar 6, 2026 | VTRS Viatris Inc | Award(A) Restricted Stock Units | 15,890 | - | - | Direct |
| Mar 6, 2026 | VTRS Viatris Inc | Exercise(M) | 1,175 | - | $0 | Direct |
| Jun 11, 2025 | CRNX Crinetics Pharmaceuticals, Inc. | Award(A) | 6,900 | - | - | Direct |
| Mar 6, 2025 | VTRS Viatris Inc | Award(A) Restricted Stock Units | 23,660 | - | - | Direct |
| Mar 4, 2025 | VTRS Viatris Inc | Exercise(M) | 424 | - | - | Direct |
| Mar 4, 2025 | VTRS Viatris Inc | Exercise(M) | 21,267 | - | - | Direct |
1-13 of 13 transactions
About Vivaldi Coelho Rogerio
Vivaldi Coelho Rogerio (SEC CIK 0001610381) files insider reports with the SEC as Director of Crinetics Pharmaceuticals, Inc. (CRNX) and Director of Viatris Inc (VTRS).
Signal8 holds 8 ownership filings by Vivaldi Coelho Rogerio, all Form 4s, filed between Mar 5, 2025 and Sep 1, 2026. Those filings report 13 transactions, from Mar 4, 2025 to Sep 1, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Vivaldi Coelho Rogerio's filings is in SAN DIEGO, CA.
Recent filings by Vivaldi Coelho Rogerio
- Sep 1, 2026: Disposition to issuer transactions of CRNX shares (2 lines, Form 4, code D).
- Jul 2, 2026: Open-market sale of CRNX shares (Form 4, code S).
- Jun 18, 2026: Grant or award of CRNX shares (Form 4, code A).
- Mar 12, 2026: Open-market sales of CRNX shares (2 lines, Form 4, code S).
- Mar 6, 2026: Option exercise of VTRS shares (Form 4, code M).
Other insiders filing for Crinetics Pharmaceuticals, Inc. (CRNX)
- WIERENGA WENDELL, Director
- Okey Stephanie, Director
- Nichols Weston, Director
- Fust Matthew K, Director
- Deardorf Caren, Director
- Bedrosian Camille L, Director